FDA Has Second Thoughts on Convalescent Plasma for COVID-19

4 years ago

by David Miller

949 Views

Written by David Miller

The FDA has reversed course and authorized convalescent plasma as an emergency use authorization for COVID-19. The scientific community does not think this was a wise course of action.Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!